A local small business is hoping to deploy technology in the coming years that could help seed producers and distributors more quickly determine the genetic makeup of their products. NanoBio Designs ...
Flush from a $14 million upfront payment from GlaxoSmithKline and in hot pursuit of an intranasal therapeutic vaccine for hepatitis B, Ann Arbor, MI-based NanoBio is bursting at the seams. The biotech ...
ANN ARBOR, Mich. (April 19, 2010) - NanoBio® Corporation today announced an initiative to develop an intranasal vaccine for the treatment of hepatitis B (HBV). NanoBio and the University of Michigan's ...
A nanoparticle may have little surface area, but it does represent a wide-open frontier in nanomedicine, which seeks to deploy nanoparticles in imaging, drug delivery, and cell reprogramming ...
ANN ARBOR, Mich.--(BUSINESS WIRE)-- Building upon a series of successful preclinical and clinical studies, NanoBio Corporation today announced the initiation of a second tolerability and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results